Literature DB >> 29960116

Association of serum zinc with markers of liver injury in very heavy drinking alcohol-dependent patients.

Vatsalya Vatsalya1, Maiying Kong2, Matthew C Cave3, Nanlong Liu4, Melanie L Schwandt5, David T George5, Vijay A Ramchandani6, Craig J McClain7.   

Abstract

Zinc deficiency is a frequent complication of alcohol abuse for multiple reasons including poor intake, increased excretion, internal redistribution and altered transporters. Zinc deficiency has been postulated to play a role in the development/progression of alcoholic liver disease (ALD). This study aimed to relate serum zinc levels with alcohol intake, serum albumin concentration and markers of inflammation and liver injury. One hundred and eight male and female very heavy drinking (≥10 drinks/day) individuals without clinical evidence of ALD were grouped by serum zinc concentration: normal-zinc group (zinc level≥71 μg/dl) included 67 patients, and low-zinc group (zinc level<71 μg/dl) included 41 patients. Data were collected on demographics, drinking history in last 90 days (heavy drinking days, HDD90 and total drinks, TD90), lifetime drinking history (LTDH) and clinical/ laboratory assessments. Our data show that in a very well-characterized, chronically heavy-drinking population without clinical evidence of liver disease, about 40% of subjects had low serum zinc levels. Frequency of heavy drinking days (HDD90) was significantly higher in the low-zinc group. Total drinks in past 90 days, LTDH and HDD90 showed significant associations with low zinc levels. The group with the low serum zinc had a higher aspartate aminotransferase/alanine aminotransferase ratio (good marker of alcoholic liver disease). Those in the low-zinc group had the lower albumin levels, a marker of hepatic synthetic function, and the highest C-reactive protein level, a biomarker of inflammation. Published by Elsevier Inc.

Entities:  

Keywords:  Alcohol; C-reactive protein; Drinking history; Liver injury; Zinc

Mesh:

Substances:

Year:  2018        PMID: 29960116      PMCID: PMC6129416          DOI: 10.1016/j.jnutbio.2018.05.003

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  37 in total

1.  Zinc metabolism in hepatic dysfunction. II. Correlation of metabolic patterns with biochemical findings.

Authors:  B L VALLEE; W E WACKER; A F BARTHOLOMAY; F L HOCH
Journal:  N Engl J Med       Date:  1957-11-28       Impact factor: 91.245

Review 2.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 3.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

4.  The nutritional index 'CONUT' is useful for predicting long-term prognosis of patients with end-stage liver diseases.

Authors:  Koji Fukushima; Yoshiyuki Ueno; Naoki Kawagishi; Yasuteru Kondo; Jun Inoue; Eiji Kakazu; Masashi Ninomiya; Yuta Wakui; Naoko Saito; Susumu Satomi; Tooru Shimosegawa
Journal:  Tohoku J Exp Med       Date:  2011-07       Impact factor: 1.848

5.  Bone and mineral metabolism and chronic alcohol abuse.

Authors:  B C Lalor; M W France; D Powell; P H Adams; T B Counihan
Journal:  Q J Med       Date:  1986-05

Review 6.  "Second hit" models of alcoholic liver disease.

Authors:  Hidekazu Tsukamoto; Keigo Machida; Alla Dynnyk; Hasmik Mkrtchyan
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

7.  Assessing drinking outcomes in alcohol treatment efficacy studies: selecting a yardstick of success.

Authors:  Linda Carter Sobell; Mark B Sobell; Gerard J Connors; Sangeeta Agrawal
Journal:  Alcohol Clin Exp Res       Date:  2003-10       Impact factor: 3.455

8.  Bone mineral density and disorders of mineral metabolism in chronic liver disease.

Authors:  Joe George; Hosahithlu K Ganesh; Shrikrishna Acharya; Tushar R Bandgar; Vyankatesh Shivane; Anjana Karvat; Shobna J Bhatia; Samir Shah; Padmavathy S Menon; Nalini Shah
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

9.  Zinc protects against tumor necrosis factor-induced disruption of porcine endothelial cell monolayer integrity.

Authors:  B Hennig; Y Wang; S Ramasamy; C J McClain
Journal:  J Nutr       Date:  1993-06       Impact factor: 4.798

10.  Tumor necrosis factor-mediated hypoalbuminemia in rabbits.

Authors:  B Hennig; R Honchel; S E Goldblum; C J McClain
Journal:  J Nutr       Date:  1988-12       Impact factor: 4.798

View more
  9 in total

1.  Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis.

Authors:  Manasa Sagaram; Ranganathan Parthasarathy; Sally L Condon; Charles F Closson; Maiying Kong; Melanie L Schwandt; Loretta L Jophlin; Wenke Feng; Ashutosh J Barve; Vatsalya Vatsalya
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

2.  The Activities of Zinc and Magnesium Among Alcohol Dependence Syndrome Patients: A Case-Control Study From a Tertiary Care Teaching Hospital in South India.

Authors:  Pratyusha Pavuluri; Sharanya Jangili; Likhitha Ryakam; Sabitha Vadakedath; Sarat Chandan Tummalacharla; Deepthi Kondu; Venkataramana Kandi
Journal:  Cureus       Date:  2022-04-26

3.  Lower Serum Magnesium Concentrations are associated With Specific Heavy Drinking Markers, Pro-Inflammatory Response and Early-Stage Alcohol-associated Liver Injury§.

Authors:  Vatsalya Vatsalya; Khushboo S Gala; Maithili Mishra; Melanie L Schwandt; John Umhau; Matthew C Cave; Dipendra Parajuli; Vijay A Ramchandani; Craig J McClain
Journal:  Alcohol Alcohol       Date:  2020-03-19       Impact factor: 2.826

Review 4.  Magnesium, Calcium, Potassium, Sodium, Phosphorus, Selenium, Zinc, and Chromium Levels in Alcohol Use Disorder: A Review.

Authors:  Jacek Baj; Wojciech Flieger; Grzegorz Teresiński; Grzegorz Buszewicz; Ryszard Sitarz; Alicja Forma; Kaja Karakuła; Ryszard Maciejewski
Journal:  J Clin Med       Date:  2020-06-18       Impact factor: 4.241

Review 5.  Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease.

Authors:  Jing Wu; Qing-Hua Meng
Journal:  World J Gastroenterol       Date:  2020-08-21       Impact factor: 5.742

6.  Characterization of Early-Stage Alcoholic Liver Disease with Hyperhomocysteinemia and Gut Dysfunction and Associated Immune Response in Alcohol Use Disorder Patients.

Authors:  Vatsalya Vatsalya; Khushboo S Gala; Ammar Z Hassan; Jane Frimodig; Maiying Kong; Nachiketa Sinha; Melanie L Schwandt
Journal:  Biomedicines       Date:  2020-12-24

7.  Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile.

Authors:  Vatsalya Vatsalya; Fengyuan Li; Jane Frimodig; Khushboo S Gala; Shweta Srivastava; Maiying Kong; Vijay A Ramchandani; Wenke Feng; Xiang Zhang; Craig J McClain
Journal:  Front Pharmacol       Date:  2021-03-02       Impact factor: 5.810

8.  Microbiome dysbiosis and alcoholic liver disease.

Authors:  Fengyuan Li; Craig J McClain; Wenke Feng
Journal:  Liver Res       Date:  2019-09-06

9.  Efficacy of Thiamine and Medical Management in Treating Hyperuricemia in AUD Patients with ALD: Role of Hyperuricemia in Liver Injury, Gut-Barrier Dysfunction, and Inflammation.

Authors:  Vatsalya Vatsalya; Fengyuan Li; Jane Frimodig; Nihar Shah; Amar Sutrawe; Wenke Feng
Journal:  Clin Exp Pharmacol       Date:  2021-07-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.